Alimera Sciences Inc (ALIM)
3.71
+0.04
(+1.09%)
USD |
NASDAQ |
Apr 30, 16:00
Alimera Sciences Free Cash Flow: -89.79M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -89.79M |
| September 30, 2023 | -93.81M |
| June 30, 2023 | -86.03M |
| March 31, 2023 | -6.086M |
| December 31, 2022 | -10.23M |
| September 30, 2022 | -14.70M |
| June 30, 2022 | -15.70M |
| March 31, 2022 | -7.622M |
| December 31, 2021 | -3.845M |
| September 30, 2021 | 0.611M |
| June 30, 2021 | 1.187M |
| March 31, 2021 | -5.921M |
| December 31, 2020 | -2.813M |
| September 30, 2020 | -2.067M |
| June 30, 2020 | -3.61M |
| March 31, 2020 | -4.072M |
| December 31, 2019 | -4.326M |
| September 30, 2019 | -4.065M |
| June 30, 2019 | -3.918M |
| March 31, 2019 | -6.32M |
| December 31, 2018 | -11.73M |
| September 30, 2018 | -14.10M |
| June 30, 2018 | -14.48M |
| March 31, 2018 | -14.02M |
| December 31, 2017 | -13.11M |
| Date | Value |
|---|---|
| September 30, 2017 | -13.87M |
| June 30, 2017 | -18.13M |
| March 31, 2017 | -22.70M |
| December 31, 2016 | -25.28M |
| September 30, 2016 | -31.79M |
| June 30, 2016 | -32.14M |
| March 31, 2016 | -37.76M |
| December 31, 2015 | -45.82M |
| September 30, 2015 | -71.67M |
| June 30, 2015 | -67.73M |
| March 31, 2015 | -58.78M |
| December 31, 2014 | -50.14M |
| September 30, 2014 | -25.63M |
| June 30, 2014 | -29.72M |
| March 31, 2014 | -35.22M |
| December 31, 2013 | -38.79M |
| September 30, 2013 | -35.17M |
| June 30, 2013 | -30.61M |
| March 31, 2013 | -25.60M |
| December 31, 2012 | -21.20M |
| September 30, 2012 | -19.08M |
| June 30, 2012 | -20.24M |
| March 31, 2012 | -21.24M |
| December 31, 2011 | -20.83M |
| September 30, 2011 | -22.29M |
Free Cash Flow Range, Past 5 Years
-93.81M
Minimum
Sep 2023
1.187M
Maximum
Jun 2021
-18.78M
Average
-4.326M
Median
Dec 2019
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.152B |
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.77M |
| Cash from Investing (Quarterly) | -0.085M |
| Cash from Financing (Quarterly) | -0.078M |
| Free Cash Flow Per Share (Quarterly) | 0.0704 |
| Free Cash Flow to Equity (Quarterly) | 3.418M |
| Free Cash Flow to Firm (Quarterly) | 8.448M |
| Free Cash Flow Yield | -97.21% |